EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Assessment of cell cycle arrest biomarkers and neutrophil gelatinase-associated lipocalin to distinguish acute kidney injury from other diseases in dogs

Ann Biscop iD, Donatienne Castelain, Emmelie Stock iD, Kristel Demeyere, Evelyne Meyer, Nausikaa Devriendt iD, Elisabeth Dorn iD, Nikita De Laet, Dominique Paepe iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17143 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Ann Biscop and 8 co-authors. Institution: Small Animal Department, Ghent University, Merelbeke, Belgium. Major MEDLINE topics: Dog Diseases, Acute Kidney Injury, Biomarkers, Tissue Inhibitor of Metalloproteinase-2. Cited 1 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: IDEXX Laboratories Inc., Sonic Healthcare Benelux.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cell cycle arrest biomarkers (tissue inhibitor of metalloproteinase-2 [uTIMP-2] and insulin-like growth factor binding protein 7 [uIGFBP7]), and neutrophil gelatinase-associated lipocalin (NGAL) variables are valuable biomarkers for early diagnosis of acute kidney injury (AKI) in people.

Objectives

To evaluate uTIMP-2, uIGFBP7, fractional excretion of NGAL (FeNGAL), and urinary to serum NGAL ratio (u/sNGAL) in healthy dogs, dogs with AKI, dogs with chronic kidney disease (CKD), and critically ill (CI) dogs. Animals Forty-two client-owned dogs (healthy, n = 10; AKI, n = 11; CKD, n = 11; CI, n = 10).

Methods

Prospective, observational study. After assessment of routine renal biomarkers, stress (uTIMP-2, uIGFBP7) and damage (NGAL) biomarkers were measured, using ELISA kits, and normalized to urinary creatinine (uCr).

Results

Normalized uTIMP-2 and [uTIMP-2] × [uIGFBP7]/uCr were significantly higher in the AKI group (median 151.9 [range, 2.2-534.2] and 62.9 [1.1-266.8] pg/mL respectively), compared to healthy dogs (0.3 [0.2-74.7]; P < .001 and 0.16 [0.1-58.1] pg/mL; P < .001), dogs with CKD (0.7 [0.3-742.5]; P = .04 and 0.37 [0.2-180.1] pg/mL; P = .03) and CI dogs (1.9 [0.2-37.0]; P = .03 and 0.8 [0.1-16.1] pg/mL; P = .02). Fractional excretion of NGAL was significantly higher in dogs with AKI (54.17 [7.93-155.32] %), than in healthy (0.03 [0.01-0.21] %; P < .001) and CI dogs (3.05 [0.05-28.86] %; P = .02). Conclusions and Clinical Importance Normalized uTIMP-2, [uTIMP-2] × [uIGFBP7]/uCr, and FeNGAL can be valuable renal biomarkers for early diagnosis of AKI in dogs.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesAcute Kidney InjuryBiomarkersTissue Inhibitor of Metalloproteinase-2Insulin-Like Growth Factor Binding ProteinsLipocalin-2AnimalsDogsMaleFemaleProspective StudiesRenal Insufficiency, ChronicCritical IllnessCell Cycle CheckpointsDiagnosis, DifferentialAcute-Phase ProteinsProto-Oncogene ProteinsLipocalins

Author keywords

canineearly diagnosisinsulin‐like growth factor binding protein 7 (IGFBP7)renal diseasesymmetric dimethylarginine (SDMA)tissue inhibitor of metalloproteinase‐2 (TIMP‐2)

Substances

BiomarkersTissue Inhibitor of Metalloproteinase-2Insulin-Like Growth Factor Binding ProteinsLipocalin-2insulin-like growth factor binding protein-related protein 1neutrophil gelatinase-associated lipocalin protein, dogAcute-Phase ProteinsProto-Oncogene ProteinsLipocalins

Authors and institutions

  • Small Animal Department, Ghent University, Merelbeke, Belgium.
  • Department of Internal Medicine, Reproduction and Population Medicine, Ghent University, Merelbeke, Belgium.
  • Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Ghent University, Merelbeke, Belgium.
  • Department of Veterinary and Biosciences, Ghent University, Merelbeke, Belgium.

ORCID profiles: Ann Biscop, Emmelie Stock, Nausikaa Devriendt, Elisabeth Dorn, Dominique Paepe

Funding

  • IDEXX Laboratories Inc.
  • Sonic Healthcare Benelux

Cite

APA

Biscop, A., Castelain, D., Stock, E., Demeyere, K., Meyer, E., Devriendt, N., Dorn, E., De Laet, N., & Paepe, D. (2024). Assessment of cell cycle arrest biomarkers and neutrophil gelatinase-associated lipocalin to distinguish acute kidney injury from other diseases in dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17143

Vancouver

Biscop A, Castelain D, Stock E, Demeyere K, Meyer E, Devriendt N, et al. Assessment of cell cycle arrest biomarkers and neutrophil gelatinase-associated lipocalin to distinguish acute kidney injury from other diseases in dogs. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17143

BibTeX
@article{Biscop2024,
  author = {Biscop, Ann and Castelain, Donatienne and Stock, Emmelie and Demeyere, Kristel and Meyer, Evelyne and Devriendt, Nausikaa and Dorn, Elisabeth and De Laet, Nikita and Paepe, Dominique},
  title = {Assessment of cell cycle arrest biomarkers and neutrophil gelatinase-associated lipocalin to distinguish acute kidney injury from other diseases in dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17143}
}
Start for free →